Pancreatic elastase 1 after pancreatic transplantation

Area of Science:

• Biochemistry
• Transplantation Immunology
• Clinical Chemistry

Background:

• Human pancreatic elastase 1 (E1) is a novel pancreas-specific proteinase.
• E1's role after pancreatic transplantation (PTx) remains largely uninvestigated.
• Pancreatic exocrine diversion is a common surgical approach in PTx.

Purpose of the Study:

• To investigate serum E1 levels in patients undergoing PTx.
• To determine if E1 can serve as a marker for pancreatic graft function and damage.
• To characterize E1 serum profiles post-PTx over an 8-year period.

Main Methods:

• Serum samples from 36 type I diabetic patients post-PTx were analyzed using a newly developed E1 ELISA.
• E1 levels were measured from pre-transplant up to 8 years post-transplant (731 samples total).
• E1 profiles were correlated with clinical events, including acute rejection and graft lesions.

Main Results:

• E1 levels peaked within 6 days post-PTx, stabilized at an elevated level (approx. 10 ng/ml) after 4-6 weeks for ~1 year.
• E1 remained slightly elevated (1-6 ng/ml) in most patients 2-8 years post-PTx.
• Increasing E1 levels >2 months post-PTx correlated with exocrine graft damage, but E1 was not a sensitive marker for early acute rejection.

Conclusions:

• E1 exhibits a characteristic pattern post-PTx, stabilizing at elevated levels.
• E1 may serve as a valuable marker for detecting exocrine pancreatic graft damage late after transplantation.
• Slightly elevated E1 levels years post-PTx are likely due to non-portal venous drainage.